| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
WBSCR1 |
EIF4H, KIAA0038, WBSCR1, WSCR1: Eukaryotic translation initiation factor 4H |
0.265 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
ACIN1 |
ACIN1, ACINUS, KIAA0670: Apoptotic chromatin condensation inducer in the nucleus |
0.265 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
0.265 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
0.265 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
EIF4G1 |
EIF4G1, EIF4F, EIF4G, EIF4GI: Eukaryotic translation initiation factor 4 gamma 1 |
0.265 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
MATR3 |
MATR3, KIAA0723: Matrin-3 |
0.265 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
CRLF3 |
IPI00295387 |
0.265 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
0.265 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
ITGAE |
ITGAE: Integrin alpha-E precursor |
0.265 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
0.265 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
0.265 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.265 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
ADAMTS1 |
ADAMTS1, KIAA1346, METH1: ADAMTS-1 precursor |
0.265 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
LUM |
LUM, LDC: Lumican precursor |
0.265 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
F11R |
F11R, JAM1, UNQ264/PRO301, JCAM: Junctional adhesion molecule A precursor |
0.265 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
0.265 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
0.265 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
H1FX |
H1FX: Histone H1x |
0.265 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
0.265 |
Evidence |
O
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
0.265 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
FOXJ2 |
FOXJ2, FHX: Forkhead box protein J2 |
0.265 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.265 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
SATB1 |
SATB1: DNA-binding protein SATB1 |
0.265 |
Evidence |
|